JENNIFER BURKE: Open Payments
NPI 1356547392 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,244 in 128 payments from 18 companies in 2025. Trend: 2023 $2,160 · 2024 $2,598 · 2025 $2,244
Food & beverage: $2,164Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $545 |
| Janssen Biotech, Inc. | 14 | $337 |
| Incyte Corporation | 15 | $236 |
| Regeneron Healthcare Solutions, Inc. | 7 | $211 |
| Galderma Laboratories, L.P. | 20 | $169 |
| UCB, Inc. | 10 | $165 |
| PFIZER INC. | 6 | $105 |
| Organon LLC | 8 | $85 |
| Arcutis Biotherapeutics, Inc. | 5 | $84 |
| Organogenesis Inc. | 4 | $81 |
Products named: TREMFYA, RINVOQ, DUPIXENT, OPZELURA, SKYRIZI, Bimzelx, NEMLUVIO, Zoryve.
Industry payments across CO — which companies pay providers there.
